Overview
Helene Lelong practices practicing medicine in Paris, France.
Her clinical expertise encompasses Hypertension, Abdominal Obesity Metabolic Syndrome, and Maturity Onset Diabetes of the Young.
She is actively involved in clinical research, co-authoring 29 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Helene L. Lelong
Is Helene L. Lelong a top-rated expert for Hypertension?
MediFind is an objective health platform that identifies experts based on real-world data. Helene L. Lelong is classified as an Experienced expert for Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Helene L. Lelong participate in research or clinical trials?
Yes. Helene L. Lelong has published 29 articles and abstracts on conditions like Hypertension. You can view a list of Helene L. Lelong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Abdominal Obesity Metabolic SyndromeMs. Lelong isExperienced. Learn about Abdominal Obesity Metabolic Syndrome.
- HypertensionMs. Lelong isExperienced. Learn about Hypertension.
- Maturity Onset Diabetes of the YoungMs. Lelong isExperienced. Learn about Maturity Onset Diabetes of the Young.